Scott McNealy
Silicon Valley Veteran Scott McNealy Joins EyecareLive's Advisory Board
October 12, 2021 09:00 ET | EyecareLive
SANTA CLARA, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- EyecareLive, a digital eye care platform and a telehealth services provider today announced that Silicon Valley veteran Scott McNealy has...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies Appoints Leading US Ophthalmic Surgeon and Researcher Dr. Henry D. Perry to its Medical Advisory Board
October 11, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
22157.jpg
Insights on the Ophthalmic Packaging Global Market to 2028 - Increasing Prevalence of Ocular Disorders is Driving Growth
September 30, 2021 04:18 ET | Research and Markets
Dublin, Sept. 30, 2021 (GLOBE NEWSWIRE) -- The "Ophthalmic Packaging Market Size, Share & Trends Analysis Report By Dose (Single Dose, Multi Dose), By Type (OTC, Prescription), By Material...
Joseph Tauber, MD
AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board
September 21, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
22157.jpg
Europe Dry Eye Market Research and Competitive Landscape Report 2021
September 20, 2021 04:53 ET | Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Europe Dry Eye Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. Europe Dry Eye Market and...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies to Acquire Technology Including Two FDA-Cleared 510(k)’s for Diagnostic Testing of Dry Eye Disease
August 03, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a leader in the development of diagnostic testing for COVID-19 and...
merakris_logo_4color copy.jpg
Merakris Announces Agreement With Miracles In Sight Eye Bank To Supply Opticyte® Repair Grafts to Eye Surgeons
July 20, 2021 06:30 ET | Merakris Therapeutics
RESEARCH TRIANGLE PARK, N.C., July 20, 2021 (GLOBE NEWSWIRE) -- Research Triangle Park-based biotechnology company Merakris Therapeutics has reached an agreement with Miracles In Sight (MIS) to...
22157.jpg
Outlook on the Artificial Tears Global Market to 2028 - by Type, Delivery Mode, Application and Geography
July 12, 2021 05:13 ET | Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application" report has been added to...
22157.jpg
Dry Eye Disease Clinical Landscape Report 2021: Novartis Leads Industry Sponsors with the Highest Overall Number of Clinical Trials, Followed by AbbVie
July 08, 2021 07:08 ET | Research and Markets
Dublin, July 08, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Dry Eye Disease" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Systemic Lupus...
22157.jpg
Outlook on the Dry Eye Disease (DED) Global Market to 2026 - Featuring Johnson & Johnson, Bausch Health and Alcon Among Others
April 29, 2021 05:13 ET | Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Global Dry Eye Disease (DED) Market - Analysis By Disease (Aqueous, Evaporative, Others), Treatment, End User, Distribution Channel, By Region, By...